α-helix structure in Alzheimer's disease aggregates of tau-protein

被引:101
|
作者
Sadqi, M
Hernández, F
Pan, UM
Pérez, M
Schaeberle, MD
Avila, J
Muñoz, V
机构
[1] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA
[2] Univ Maryland, Ctr Biomol Struct & Org, College Pk, MD 20742 USA
[3] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain
[4] NIDDKD, Phys Chem Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1021/bi025777e
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The discovery of beta-sheet structure in Alzheimer's amyloid fibrils, and then in many other disease-related protein fibrils, has led to the widely believed view that beta-sheet formation is the general mechanism of aberrant protein aggregation leading to disease. This notion is further reinforced by recent findings, which indicate that normal proteins can be induced to form beta-sheet fibrils in vitro. Alzheimer's disease, a paradigm proteopathy, is accompanied by the formation of two distinct aggregates, amyloid fibrils and paired helical filaments (PHFs). Electron microscope images of PHFs show pairs of twisted ribbons with 80 nm periodicity. However, there is little information of the molecular structure of PHFs, as previous studies have failed to identify signs of regular structure. Using far-UV circular dichroism and Fourier-transformed infrared spectroscopy, we find that PHFs are comprised of alpha-helices. This is remarkable as tau-protein, PHF's primary constituent, has a high abundance of helix-breaking amino acids and is unstructured in solution. We also find that PHFs are very stable, as judged by their high melting temperature and resistance to protease digestion. PHFs are the first example of pathological aggregation associated to the formation of alpha-helix.
引用
收藏
页码:7150 / 7155
页数:6
相关论文
共 50 条
  • [21] ALUMINUM, TAU-PROTEIN, AND ALZHEIMERS-DISEASE
    WISNIEWSKI, HM
    LANCET, 1994, 344 (8916): : 204 - 205
  • [22] Tau protein: A potential biological indicator for early recognition of Alzheimer's disease [Tau-protein: Ein potentieller biologischer Indikator zur Fruherkennung der Alzheimer-Krankheit]
    Buch K.
    Riemenschneider M.
    Bartenstein P.
    Willoch F.
    Müller U.
    Schmolke M.
    Nolde T.
    Steinmann C.
    Guder W.G.
    Kurz A.
    Der Nervenarzt, 1998, 69 (5) : 379 - 385
  • [23] Autophagic Pathways to Clear the Tau Aggregates in Alzheimer’s Disease
    Nalini Vijay Gorantla
    Subashchandrabose Chinnathambi
    Cellular and Molecular Neurobiology, 2021, 41 : 1175 - 1181
  • [24] Autophagic Pathways to Clear the Tau Aggregates in Alzheimer's Disease
    Gorantla, Nalini Vijay
    Chinnathambi, Subashchandrabose
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2021, 41 (06) : 1175 - 1181
  • [25] TAU-PROTEIN AND NEURODEGENERATION
    KOSIK, KS
    MOLECULAR NEUROBIOLOGY, 1990, 4 (3-4) : 171 - 179
  • [26] Targeting Tau Protein in Alzheimer’s Disease
    Cheng-Xin Gong
    Inge Grundke-Iqbal
    Khalid Iqbal
    Drugs & Aging, 2010, 27 : 351 - 365
  • [27] Alzheimer's disease:: β-amyloid protein and tau
    Morishima-Kawashima, M
    Hara, Y
    JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 70 (03) : 392 - 401
  • [28] Extra-brain expression of tau-protein: New possibilities for life-time diagnosis of Alzheimer's disease
    Kvetnoy, I.
    Paltsev, M.
    Kvetnaia, T.
    Polyakova, V.
    Konovalov, S.
    Gurko, G.
    Mursalov, S.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 318 - 319
  • [29] Targeting tau protein in Alzheimer's disease
    Rafii, Michael S.
    LANCET, 2016, 388 (10062): : 2842 - 2844
  • [30] Targeting Tau Protein in Alzheimer's Disease
    Gong, Cheng-Xin
    Grundke-Iqbal, Inge
    Iqbal, Khalid
    DRUGS & AGING, 2010, 27 (05) : 351 - 365